Business Context and Reporting Period
This Form 8-K Current Report was filed by OraSure Technologies, Inc. on September 23, 2005. The filing discloses the appointment of a new executive officer and the execution of a material definitive employment agreement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation and appointment details.
Material Changes and Executive Appointment
On September 23, 2005, the Company appointed Stephen R. Lee, Ph.D., as Executive Vice President and Chief Science Officer. Dr. Lee will direct the Company's research and development activities. He brings twenty years of experience in the immunodiagnostic industry, primarily from Ortho Clinical Diagnostics (Johnson & Johnson), where he developed over 40 major diagnostic assays.
Employment Agreement Terms and Compensation
- Base Salary: At least $250,000 annually.
- Cash Bonus: Annual target of at least 40% of base salary; a specific bonus of at least $75,000 for 2005 performance.
- Legal Expense Reimbursement: Up to $10,000 for expenses incurred in joining the Company.
- Equity Grants:
- Option to purchase 125,000 shares of common stock (vesting over 4 years).
- Grant of 40,000 restricted shares (vesting over 3 years).
- Term: Initial term of 2 years with automatic renewal for successive 2-year periods.
- Termination Provisions: Includes severance of 12 to 18 months' salary and acceleration of unvested equity awards under specific circumstances, including change of control.
Investor Verification Checklist
- Verify the vesting schedule and exercise price of the 125,000 stock options granted to Dr. Lee.
- Review the specific conditions triggering the 12 or 18-month severance payment and equity acceleration.
- Confirm the total potential cash compensation impact for the fiscal year 2005, including the $75,000 performance bonus.
- Assess the impact of this new executive appointment on the Company's R&D pipeline and strategic direction.